Biocon: Considers Early Redemption of Unlisted Debentures
Biocon is considering the early redemption of 1,07,000 unlisted, secured, rated, redeemable, Non-Convertible Debentures (NCDs) with a face…
Cohance Lifesciences: Board to Consider Unaudited Financial Results on November 12, 2025
The Board of Directors of Cohance Lifesciences Limited will meet on November 12, 2025, to consider and approve the unaudited financial results…
KFin Technologies: Board Meeting Scheduled for October 27, 2025
KFin Technologies has announced a board meeting scheduled for October 27, 2025, to review and approve the unaudited financial results for the…
Poonawalla Fincorp: Trading Window Closure and Board Meeting Announcement
Poonawalla Fincorp Limited announced the closure of its trading window for designated persons and their immediate relatives from October 1,…
Gujarat Gas: Board Meeting Scheduled to Consider Quarterly Results
The Board of Directors of Gujarat Gas is scheduled to meet on November 7, 2025, to consider and approve the standalone and consolidated…
IDFC FIRST Bank: Board to Approve Unaudited Standalone Results on October 18, 2025
IDFC FIRST Bank has announced a board meeting scheduled for October 18, 2025, to consider and approve the unaudited standalone financial…
Atul Ltd: Board Meeting Scheduled to Approve Q2 FY26 Results
Atul Ltd has announced a board meeting to be held on October 17, 2025, to consider the unaudited standalone and consolidated financial results…
Hindalco: Board Meeting Scheduled to Approve Unaudited Financial Results
Hindalco Industries has announced a board meeting scheduled for November 7, 2025, to consider and approve the unaudited standalone and…
Kansai Nerolac: Board Meeting on November 3rd, Trading Window Closure
Kansai Nerolac Paints Limited will hold a Board Meeting on November 3rd, 2025, to consider unaudited financial results for the quarter and six…
Dabur India: Board to Consider Unaudited Financial Results and Interim Dividend
The Board Meeting of Dabur India is scheduled for October 30, 2025, to consider and approve the unaudited financial results for the quarter…